162 related articles for article (PubMed ID: 12235799)
1. [The ubiquitin-proteasome system and neurodegeneration].
Wada K; Osaka H; Aoki S; Wang YL
Rinsho Shinkeigaku; 2001 Dec; 41(12):1072-4. PubMed ID: 12235799
[TBL] [Abstract][Full Text] [Related]
2. Intragenic deletion in the gene encoding ubiquitin carboxy-terminal hydrolase in gad mice.
Saigoh K; Wang YL; Suh JG; Yamanishi T; Sakai Y; Kiyosawa H; Harada T; Ichihara N; Wakana S; Kikuchi T; Wada K
Nat Genet; 1999 Sep; 23(1):47-51. PubMed ID: 10471497
[TBL] [Abstract][Full Text] [Related]
3. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease.
Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA
J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595
[TBL] [Abstract][Full Text] [Related]
4. [Parkinson's disease: what have we learned from the genes responsible for familial forms?].
Corti O; Brice A
Med Sci (Paris); 2003 May; 19(5):613-9. PubMed ID: 12836396
[TBL] [Abstract][Full Text] [Related]
5. Loss of Uch-L1 and Uch-L3 leads to neurodegeneration, posterior paralysis and dysphagia.
Kurihara LJ; Kikuchi T; Wada K; Tilghman SM
Hum Mol Genet; 2001 Sep; 10(18):1963-70. PubMed ID: 11555633
[TBL] [Abstract][Full Text] [Related]
6. Gadzooks!
MacDonald ME
Nat Genet; 1999 Sep; 23(1):10-1. PubMed ID: 10471487
[No Abstract] [Full Text] [Related]
7. Proteolytic stress: a unifying concept for the etiopathogenesis of Parkinson's disease.
McNaught KS; Olanow CW
Ann Neurol; 2003; 53 Suppl 3():S73-84; discussion S84-6. PubMed ID: 12666100
[TBL] [Abstract][Full Text] [Related]
8. Delta12-Prostaglandin J2 inhibits the ubiquitin hydrolase UCH-L1 and elicits ubiquitin-protein aggregation without proteasome inhibition.
Li Z; Melandri F; Berdo I; Jansen M; Hunter L; Wright S; Valbrun D; Figueiredo-Pereira ME
Biochem Biophys Res Commun; 2004 Jul; 319(4):1171-80. PubMed ID: 15194490
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis and association studies of the ubiquitin carboxy-terminal hydrolase L1 gene in Huntington's disease.
Nazé P; Vuillaume I; Destée A; Pasquier F; Sablonnière B
Neurosci Lett; 2002 Aug; 328(1):1-4. PubMed ID: 12123845
[TBL] [Abstract][Full Text] [Related]
10. A role of the ubiquitin-proteasome system in neuropathic pain.
Moss A; Blackburn-Munro G; Garry EM; Blakemore JA; Dickinson T; Rosie R; Mitchell R; Fleetwood-Walker SM
J Neurosci; 2002 Feb; 22(4):1363-72. PubMed ID: 11850463
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin dimers control the hydrolase activity of UCH-L3.
Setsuie R; Sakurai M; Sakaguchi Y; Wada K
Neurochem Int; 2009; 54(5-6):314-21. PubMed ID: 19154770
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the testis in congenitally ubiquitin carboxy-terminal hydrolase-1 (Uch-L1) defective (gad) mice.
Kwon J; Kikuchi T; Setsuie R; Ishii Y; Kyuwa S; Yoshikawa Y
Exp Anim; 2003 Jan; 52(1):1-9. PubMed ID: 12638230
[TBL] [Abstract][Full Text] [Related]
13. Testing the ubiquitin-proteasome hypothesis of neurodegeneration in vivo.
Hernández F; Díaz-Hernández M; Avila J; Lucas JJ
Trends Neurosci; 2004 Feb; 27(2):66-9. PubMed ID: 15106649
[TBL] [Abstract][Full Text] [Related]
14. [Parkin, alpha-synuclein and other molecular aspects of Parkinson's disease].
Corti O; Brice A
J Soc Biol; 2002; 196(1):95-10. PubMed ID: 12134640
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin C-terminal hydrolase-L1 (UCH-L1) as a therapeutic and diagnostic target in neurodegeneration, neurotrauma and neuro-injuries.
Wang KK; Yang Z; Sarkis G; Torres I; Raghavan V
Expert Opin Ther Targets; 2017 Jun; 21(6):627-638. PubMed ID: 28434268
[TBL] [Abstract][Full Text] [Related]
16. Expression of alpha-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson's disease.
Solano SM; Miller DW; Augood SJ; Young AB; Penney JB
Ann Neurol; 2000 Feb; 47(2):201-10. PubMed ID: 10665491
[TBL] [Abstract][Full Text] [Related]
17. Monitoring the ubiquitin/proteasome system in conformational diseases.
Lindsten K; Dantuma NP
Ageing Res Rev; 2003 Oct; 2(4):433-49. PubMed ID: 14522245
[TBL] [Abstract][Full Text] [Related]
18. A polymorphic variation of serine to tyrosine at codon 18 in the ubiquitin C-terminal hydrolase-L1 gene is associated with a reduced risk of sporadic Parkinson's disease in a Japanese population.
Satoh J; Kuroda Y
J Neurol Sci; 2001 Aug; 189(1-2):113-7. PubMed ID: 11535241
[TBL] [Abstract][Full Text] [Related]
19. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.
Liu Y; Fallon L; Lashuel HA; Liu Z; Lansbury PT
Cell; 2002 Oct; 111(2):209-18. PubMed ID: 12408865
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitin C-Terminal Hydrolase L1 is required for regulated protein degradation through the ubiquitin proteasome system in kidney.
Radón V; Czesla M; Reichelt J; Fehlert J; Hammel A; Rosendahl A; Knop JH; Wiech T; Wenzel UO; Sachs M; Reinicke AT; Stahl RAK; Meyer-Schwesinger C
Kidney Int; 2018 Jan; 93(1):110-127. PubMed ID: 28754552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
